Obstetrics Device Global Market Report 2025

The obstetrics device market size has grown strongly in recent years. It will grow from $4.24 billion in 2024 to $4.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historical period was driven by increasing birth rates in developing nations, a rise in institutional deliveries, higher cesarean section frequencies, greater awareness of prenatal care, and government-initiated maternal health programs.

The obstetrics device market size is expected to see strong growth in the next few years. It will grow to $5.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The projected growth is fueled by a heightened global focus on lowering maternal mortality rates, an aging maternal population in developed countries, ongoing improvements in healthcare infrastructure across emerging economies, a rise in fertility treatments, and broader health insurance coverage. Key trends anticipated during this period include the integration of artificial intelligence (AI) and machine learning, advanced imaging solutions, smart and customized delivery rooms, eco-conscious and sustainable product innovations, and wearable and intelligent monitoring technologies.

The growing emphasis on maternal health is expected to drive the expansion of the obstetrics device market in the coming years. Maternal health encompasses the well-being of women throughout pregnancy, childbirth, and the postpartum period. This rising focus is attributed to increased awareness and global efforts by governments and organizations to reduce maternal mortality and enhance pregnancy outcomes. Obstetrics devices contribute to maternal health by offering accurate monitoring and diagnostic tools, which help in the early detection of complications and promote safer pregnancies. These devices aid in improved clinical decision-making and better outcomes for both mothers and infants. For example, in April 2025, the Centers for Disease Control and Prevention, a U.S.-based government agency, reported that the number of births in 2024 reached 3,622,673, reflecting a 1% increase from 3,591,328 in 2023. As a result, the rising focus on maternal health is propelling the growth of the obstetrics device market.

Companies in the obstetrics device market are increasingly developing technologically advanced products, such as high-end ultrasound systems, to enhance diagnostic accuracy and streamline workflows in obstetric and cardiovascular care. A premium ultrasound system is a sophisticated imaging tool that offers superior image quality and state-of-the-art technology for precise evaluations. For instance, in September 2024, Samsung Medison Co. Ltd., a South Korea-based medical device company, introduced the HERA Z20, a premium ultrasound system for obstetrics and gynecology. The HERA Z20 is equipped with advanced imaging capabilities that provide exceptional clarity and accuracy, improved diagnostic features tailored to women's health, and an intuitive interface that boosts workflow efficiency. It also incorporates artificial intelligence (AI)-powered tools to assist clinicians in making faster, more accurate decisions, setting a new benchmark in ultrasound systems for obstetrics and gynecology.

In September 2024, Samsung Medison Co. Ltd., a South Korea-based medical device manufacturer, acquired Sonio SAS for $92.4 million (€86 million). This acquisition aims to strengthen Samsung Medison’s maternal-fetal ultrasound offerings by integrating Sonio’s AI-powered decision-support software, which enhances prenatal ultrasound operations and improves the identification of abnormalities. Sonio SAS is a France-based medical technology company specializing in obstetrics devices.

Major players in the obstetrics device market are Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton, Dickinson and Company, Royal Philips N.V., Stryker Corporation, GE Healthcare, Boston Scientific Corporation, Olympus Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd., Hologic Inc., Mindray Medical International Limited, CooperSurgical Inc., Canon Medical Systems Corporation, Karl Storz GmbH & Co. KG, Cook Medical Incorporated, Natus Medical Incorporated, Esaote SpA, Atom Medical Corporation, and CHISON Medical Technologies Co Ltd.

North America was the largest region in the obstetrics device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in obstetrics device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the obstetrics device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An obstetrics device refers to a specialized medical tool or equipment designed to aid in monitoring, diagnosing, and supporting the well-being of pregnant women and their unborn babies. The primary objective of these devices is to promote a safe pregnancy and childbirth experience by providing accurate health data for both the fetus and the mother.

Obstetrics devices are mainly categorized into monitoring devices, surgical instruments, diagnostic devices, and catheters. Monitoring devices in obstetrics are used to continuously or intermittently assess the health conditions of the mother and fetus throughout pregnancy, labor, and delivery. These devices utilize various technologies such as digital monitoring, ultrasound imaging, and wireless communication. They are employed in applications including pregnancy monitoring, labor and delivery, cesarean procedures, neonatal care, and reproductive health. The primary end users of these devices include hospitals, clinics, birthing centers, and ambulatory surgical centers.

The obstetrics device market research report is one of a series of new reports that provides obstetrics device market statistics, including obstetrics device industry global market size, regional shares, competitors with a obstetrics device market share, obstetrics device market segments, market trends and opportunities, and any further data you may need to thrive in the obstetrics device industry. This obstetrics device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obstetrics device market consists of sales of fetal monitors, ultrasound systems, obstetric forceps, vacuum extractors, birthing beds, and other related medical instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.